Eli Lilly plans to increase the price of Mounjaro in the UK by up to 170% starting in September. The cost of a month's supply of the highest dose will rise from 122 to 330. The initial lower price was set to expedite access through the NHS. Although the new list price aligns more closely with European markets, the NHS will continue to ensure that patients with obesity and type 2 diabetes retain access without facing the increased cost. Eli Lilly is negotiating discounts with private healthcare providers.
Eli Lilly will increase the price of Mounjaro by up to 170% in the UK, with a month's supply of the highest dose rising from 122 to 330.
The increased list price of Mounjaro aligns it more consistently with other European markets, as Eli Lilly initially set a lower price to ensure NHS availability.
Donald Trump has threatened pharmaceutical companies to lower drug prices for Americans, emphasizing that the US pays about three times more for drugs than other developed countries.
Eli Lilly is working with private healthcare providers for confidential discounts, while the NHS will not pay the higher price to maintain access for patients.
Collection
[
|
...
]